Cargando…

环状RNA在肿瘤免疫治疗中的研究进展

Tumor immunotherapy is a new therapy which developed in recent years, it has greatly changed the therapeutic schedules and brought new options for patients. However, not all patients can have obvious therapeutic effects after using immunotherapy. So selecting more suitable patients and raising immun...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560983/
https://www.ncbi.nlm.nih.gov/pubmed/34628781
http://dx.doi.org/10.3779/j.issn.1009-3419.2021.101.31
_version_ 1784593037602586624
collection PubMed
description Tumor immunotherapy is a new therapy which developed in recent years, it has greatly changed the therapeutic schedules and brought new options for patients. However, not all patients can have obvious therapeutic effects after using immunotherapy. So selecting more suitable patients and raising immunotherapy effect are worthy to discuss. With the research of circular RNAs (circRNAs), circRNAs have been found that they not only play a significant role in the field of tumor markers, tumor progression and prognosis, but also can abnormally express in a variety of tumors and affect tumor immunity. Therefore, the circRNAs expression may not only can be used as a supplementary method for selecting patients, but also can be used to predict the efficacy of tumor immunotherapy. In this article, we summarize current knowledge on circRNAs abnormally expressed in many cancers, especially lung cancer which can affect tumor immunity, and discuss its potential effects in tumor immunotherapy, and we hope to provide more references for the clinical practice of circRNAs.
format Online
Article
Text
id pubmed-8560983
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-85609832021-11-10 环状RNA在肿瘤免疫治疗中的研究进展 Zhongguo Fei Ai Za Zhi 综述 Tumor immunotherapy is a new therapy which developed in recent years, it has greatly changed the therapeutic schedules and brought new options for patients. However, not all patients can have obvious therapeutic effects after using immunotherapy. So selecting more suitable patients and raising immunotherapy effect are worthy to discuss. With the research of circular RNAs (circRNAs), circRNAs have been found that they not only play a significant role in the field of tumor markers, tumor progression and prognosis, but also can abnormally express in a variety of tumors and affect tumor immunity. Therefore, the circRNAs expression may not only can be used as a supplementary method for selecting patients, but also can be used to predict the efficacy of tumor immunotherapy. In this article, we summarize current knowledge on circRNAs abnormally expressed in many cancers, especially lung cancer which can affect tumor immunity, and discuss its potential effects in tumor immunotherapy, and we hope to provide more references for the clinical practice of circRNAs. 中国肺癌杂志编辑部 2021-10-20 /pmc/articles/PMC8560983/ /pubmed/34628781 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.101.31 Text en 版权所有©《中国肺癌杂志》编辑部2021 https://creativecommons.org/licenses/by/3.0/This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/.
spellingShingle 综述
环状RNA在肿瘤免疫治疗中的研究进展
title 环状RNA在肿瘤免疫治疗中的研究进展
title_full 环状RNA在肿瘤免疫治疗中的研究进展
title_fullStr 环状RNA在肿瘤免疫治疗中的研究进展
title_full_unstemmed 环状RNA在肿瘤免疫治疗中的研究进展
title_short 环状RNA在肿瘤免疫治疗中的研究进展
title_sort 环状rna在肿瘤免疫治疗中的研究进展
topic 综述
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560983/
https://www.ncbi.nlm.nih.gov/pubmed/34628781
http://dx.doi.org/10.3779/j.issn.1009-3419.2021.101.31
work_keys_str_mv AT huánzhuàngrnazàizhǒngliúmiǎnyìzhìliáozhōngdeyánjiūjìnzhǎn
AT huánzhuàngrnazàizhǒngliúmiǎnyìzhìliáozhōngdeyánjiūjìnzhǎn
AT huánzhuàngrnazàizhǒngliúmiǎnyìzhìliáozhōngdeyánjiūjìnzhǎn
AT huánzhuàngrnazàizhǒngliúmiǎnyìzhìliáozhōngdeyánjiūjìnzhǎn